GB201718838D0 - Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases - Google Patents
Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseasesInfo
- Publication number
- GB201718838D0 GB201718838D0 GBGB1718838.4A GB201718838A GB201718838D0 GB 201718838 D0 GB201718838 D0 GB 201718838D0 GB 201718838 A GB201718838 A GB 201718838A GB 201718838 D0 GB201718838 D0 GB 201718838D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compounds
- treatment
- pharmaceutical compositions
- fibrotic diseases
- fibrotic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000003176 fibrotic effect Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Priority Applications (19)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1718838.4A GB201718838D0 (en) | 2017-11-15 | 2017-11-15 | Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases |
| RU2020119415A RU2020119415A (en) | 2017-11-15 | 2018-11-15 | COMPOUNDS AND THEIR PHARMACEUTICAL COMPOSITIONS FOR USE IN THE TREATMENT OF FIBROUS DISEASES |
| MA050905A MA50905A (en) | 2017-11-15 | 2018-11-15 | COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR USE IN THE TREATMENT OF FIBROTIC DISEASES |
| KR1020207016903A KR20200088844A (en) | 2017-11-15 | 2018-11-15 | Compounds for use in the treatment of fibrotic diseases and pharmaceutical compositions thereof |
| CN201880074060.4A CN111343986A (en) | 2017-11-15 | 2018-11-15 | Compounds and pharmaceutical compositions thereof for the treatment of fibrotic diseases |
| AU2018367193A AU2018367193A1 (en) | 2017-11-15 | 2018-11-15 | Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases |
| US16/764,489 US20210106582A1 (en) | 2017-11-15 | 2018-11-15 | Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases |
| JP2020526530A JP2021502987A (en) | 2017-11-15 | 2018-11-15 | Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases |
| EP23150594.2A EP4186507A1 (en) | 2017-11-15 | 2018-11-15 | Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases |
| BR112020008425-5A BR112020008425A2 (en) | 2017-11-15 | 2018-11-15 | compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases |
| CA3082742A CA3082742A1 (en) | 2017-11-15 | 2018-11-15 | Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases |
| MX2020004810A MX2020004810A (en) | 2017-11-15 | 2018-11-15 | Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases. |
| SG11202004408YA SG11202004408YA (en) | 2017-11-15 | 2018-11-15 | Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases |
| EP18822268.1A EP3710004A1 (en) | 2017-11-15 | 2018-11-15 | Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases |
| PCT/EP2018/081457 WO2019096944A1 (en) | 2017-11-15 | 2018-11-15 | Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases |
| IL274578A IL274578A (en) | 2017-11-15 | 2020-05-11 | Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases |
| PH12020550616A PH12020550616A1 (en) | 2017-11-15 | 2020-05-12 | Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases |
| CONC2020/0005919A CO2020005919A2 (en) | 2017-11-15 | 2020-05-14 | Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases |
| US17/981,220 US20230241068A1 (en) | 2017-11-15 | 2022-11-04 | Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1718838.4A GB201718838D0 (en) | 2017-11-15 | 2017-11-15 | Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201718838D0 true GB201718838D0 (en) | 2017-12-27 |
Family
ID=60788453
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1718838.4A Ceased GB201718838D0 (en) | 2017-11-15 | 2017-11-15 | Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB201718838D0 (en) |
-
2017
- 2017-11-15 GB GBGB1718838.4A patent/GB201718838D0/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202004025B (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of diseases | |
| IL274578A (en) | Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases | |
| IL263641A (en) | Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseases | |
| ZA201908165B (en) | Compounds for the prevention and treatment of diseases and the use thereof | |
| PL3577135T3 (en) | A pharmaceutical composition for use in the treatment or prevention of c5-related diseases | |
| IL273959A (en) | Methods and compositions for the treatment of rare diseases | |
| IL253195B (en) | Pharmaceutical compositions comprising synthetic glycans for use in treatment of gastrointestinal diseases and methods of preparing them" | |
| IL279397A (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of diseases | |
| EP3268007A4 (en) | Compositions and therapeutic methods for the treatment of complement-associated diseases | |
| IL272937A (en) | Compositions and methods for the treatment of fibrotic diseases | |
| ZA201804950B (en) | Indolinones compounds and their use in the treatment of fibrotic diseases | |
| IL266486A (en) | Pharmaceutical compositions and methods for the treatment of cancer | |
| IL272495A (en) | Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases | |
| IL261431B (en) | Selenogalactoside compounds for the prevention and treatment of diseases associated with galectin and the use thereof | |
| IL249860A0 (en) | Pharmaceutical compositions, methods for their preparation and their use in the treatment of cancer | |
| ZA201804589B (en) | Pharmaceutical formulations and their use for the treatment of retinitis pigmentosa | |
| SMT202100070T1 (en) | Complex and compositions for the treatment of ophthalmic and dermatological diseases | |
| EP3458058C0 (en) | A pharmaceutical composition and the use thereof in the treatment of autoimmune diseases | |
| GB201410869D0 (en) | Novel pharmaceutical formulations and their use in the treatment of periodontal disease | |
| IL257689A (en) | Pharmaceutical compositions and methods for the treatment of hypoxia-related diseases | |
| GB201718838D0 (en) | Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases | |
| GB201712742D0 (en) | Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases | |
| ZA201801945B (en) | Compositions and methods for the treatment of parkinson's disease | |
| HK40036525A (en) | Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases | |
| HK40030474A (en) | Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |